Forsøksdyr: Fenbendazole-medicated feed intake study in Atlantic Salmon

Godkjenningsdato 27.06.2020

Godkjenningsperiode 03.08.2020-25.09.2020

1 Purpose: To assess the intake of different medicated feeds containing Panacur AquaSol (Fenbenzadole) focusing on manufacturing aspects to increase the feed consumption

2 Distress: Reduction of medicated feed intake due to low palatability of Panacur AquaSol pharmaceutical formulation

3 Expected benefit: The current trial will help to develop an optimal manufacturing methodology for medicated feed containing Panacur AquaSol

4 Number of animals, and what kind: Atlantic salmon (ca. 300 g) will be graded into 24 0,45 m3 tanks with 30 fish per tank in two consecutive trials (total of 1440 fish)

5 How to adhere to 3R: Alternatives to the current trial have been considered and numbers of fish have been carefully assessed in order to minimize numbers whilst not compromising scientific statistical relevance